[ CAS No. 1150617-54-1 ]

{[proInfo.proName]}
Cat. No.: {[proInfo.prAm]}
2D
Chemical Structure| 1150617-54-1
Chemical Structure| 1150617-54-1
Structure of 1150617-54-1

Quality Control of [ 1150617-54-1 ]

Purity: {[proInfo.showProBatch.pb_purity]}

Related Doc. of [ 1150617-54-1 ]

SDS

Product Details of [ 1150617-54-1 ]

CAS No. :1150617-54-1MDL No. :MFCD12024534
Formula :C6H4BrN3Boiling Point :-
Linear Structure Formula :-InChI Key :-
M.W :198.02Pubchem ID :40152259
Synonyms :

Computed Properties of [ 1150617-54-1 ]

TPSA : 41.6 H-Bond Acceptor Count : 2
XLogP3 : 1.3 H-Bond Donor Count : 1
SP3 : 0.00 Rotatable Bond Count : 0

Safety of [ 1150617-54-1 ]

Signal Word:WarningClassN/A
Precautionary Statements:P280-P305 P351 P338UN#:N/A
Hazard Statements:H302Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1150617-54-1 ]

  • Upstream synthesis route of [ 1150617-54-1 ]
  • Downstream synthetic route of [ 1150617-54-1 ]

[ 1150617-54-1 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 1301214-71-0 ]
  • [ 1150617-54-1 ]
YieldReaction ConditionsOperation in experiment
77%
Stage #1: With potassium acetate; acetic anhydride; acetic acid In chloroform at 20℃; for 0.25 h;
Stage #2: With isopentyl nitrite In chloroform at 40 - 60℃;
Stage #3: With sodium hydroxide In methanol; water at 0 - 20℃;
To a solution of N-(5-bromo-2-methylpyridin-3-yl)acetamide (8.28 g, 36 mmol) in chloroform (550 mL) at ambient temperature was added potassium acetate (4.32 g, 43.6 mmol), acetic acid (2.5 mL, 43.6 mmol) and followed by acetic anhydride (6.86 mL, 72.6 mmol).
The mixture was stirred at ambient temperature for 15 minutes before being heated to 40° C.
IsoamyInitrite was then added dropwise.
The reaction was then stirred at 60° C. for 48 hours.
The reaction mixture was poured slowly into a saturated solution of sodium bicarbonate (500 mL) at 0° C.
The organic phase was retained and the aqueous phase extracted with dichloromethane (500 mL).
The combined organics were then concentrated to a brown oil which was dissolved in methanol (500 mL).
Aqueous sodium hydroxide (2 M, 500 mL) was added at 0° C. and the mixture stirred at ambient temperature for 1 hour before the methanol was removed in vacuo.
The aqueous mixture was then extracted with ethyl acetate (3*500 mL).
The combined organics dried over magnesium sulfate, and the solvent removed in vacuo to give 6-bromo-1H-pyrazolo[4,3-b]pyridine as a light brown solid (5.5 g, 27.9 mmol, 77percent).
1HNMR (400, CD3OD): δ ppm 8.55 (s, 1H), 8.24 (s, 1H), 8.21 (s, 1H).
77% With potassium acetate; acetic anhydride; isopentyl nitrite In chloroform; acetic acid at 20 - 60℃; To a solution of N-(5-bromo-2-methylpyridin-3-yl)acetamide (8.28 g, 36 mmol) in chloroform (550 mL) at ambient temperature was added potassium acetate (4.32 g, 43.6 mmol), acetic acid (2.5 mL, 43.6 mmol) and followed by acetic anhydride (6.86 mL, 72.6 mmol). The mixture was stirred at ambient temperature for 15 minutes before being heated to 40 °C. Isoamylnitrite was then added dropwise. The reaction was then stirred at 60 °C for 48 hours. The reaction mixture was poured slowly into a saturated solution of sodium bicarbonate (500 mL) at 0 °C. The organic phase was retained and the aqueous phase extracted with dichloromethane (500 mL). The combined organics were then concentrated to a brown oil which was dissolved in methanol (500 mL). Aqueous sodium hydroxide (2 M, 500 mL) was added at 0 °C and the mixture stirred at ambient temperature for 1 hour before the methanol was removed in vacuo. The aqueous mixture was then extracted with ethyl acetate (3 x 500 mL). The combined organics dried over magnesium sulfate, and the solvent removed in vacuo to give 6-bromo-1H-pyrazolo[4,3-b]pyridine as a light brown solid (5.5 g, 27.9 mmol, 77 percent). 1HNMR (400, CD3OD): ppm 8.55 (s, 1 H), 8.24 (s, 1 H), 8.21 (s, 1 H).
77%
Stage #1: With potassium acetate; acetic anhydride; acetic acid In chloroform at 20 - 60℃; for 48.25 h;
Stage #2: With water; sodium hydroxide In methanol at 0 - 20℃;
To a solution of N-(5-bromo-2-methylpyridin-3-yl)acetamide (8.28 g, 36 mmol) in chloroform (550 mL) at ambient temperature was added potassium acetate (4.32 g, 43.6 mmol), acetic acid (2.5 mL, 43.6 mmol) and followed by acetic anhydride (6.86 mL, 72.6 mmol). The mixture was stirred at ambient temperature for 15 minutes before being heated to 40° C. Isoamylnitrite was then added dropwise. The reaction was then stirred at 60° C. for 48 hours. The reaction mixture was poured slowly into a saturated solution of sodium bicarbonate (500 mL) at 0° C. The organic phase was retained and the aqueous phase extracted with dichloromethane (500 mL). The combined organics were then concentrated to a brown oil which was dissolved in methanol (500 mL). Aqueous sodium hydroxide (2 M, 500 mL) was added at 0° C. and the mixture stirred at ambient temperature for 1 hour before the methanol was removed in vacuo. The aqueous mixture was then extracted with ethyl acetate (3.x.500 mL). The combined organics were dried over magnesium sulfate, filtered, and the solvent removed in vacuo to give 6-bromo-1H-pyrazolo[4,3-b]pyridine as a light brown solid (5.5 g, 77percent). 1HNMR (400 MHz, CD3OD, δ): 8.55 (s, 1H), 8.24 (s, 1H), 8.21 (s, 1H).
77%
Stage #1: With potassium acetate; acetic anhydride; acetic acid In chloroform at 20 - 40℃;
Stage #2: With tert.-butylnitrite In chloroform at 60℃; for 48.00 h;
Stage #3: With water; sodium hydroxide In methanol at 0 - 20℃;
To a solution of N-(5- bromo-2-methylpyridin-3-yl)acetamide (M-3) (8.3 g, 36 mmol) in chloroform (550 mL) at ambient temperature was added potassium acetate (4.3 g, 43.6 mmol), acetic acid (2.5 mL, 43.6 mmol) and followed by acetic anhydride (6.9 mL, 72.6 mmol). The mixture was stirred at ambient temperature for 15 minutes before being heated to 40 °C. Jert-butyl nitrite (6.5 mL, 54 mmol) was then added dropwise. The reaction was then stirred at 60 °C for 48 hours. The reaction mixture was poured slowly into a saturated solution of sodium bicarbonate (500 mL) at 0 °C. The organic phase was retained and the aqueous phase extracted with dichloromethane (500 mL). The combined organics were then concentrated to a brown oil which was dissolved in methanol (500 mL). Aqueous sodium hydroxide (2 M, 500 mL) was added at 0 °C and the mixture stirred at ambient temperature for 1 hour before the methanol was removed in vacuo. The aqueous mixture was then extracted with ethyl acetate (3 χ 500 mL). The combined organics dried over magnesium sulfate, and the solvent removed in vacuo to give the title compound as a light brown solid (5.5 g, 27.9 mmol, 77percent). 1HNMR (400, CD3OD): δ ppm 8.55 (s, 1H), 8.24 (s, 1H), 8.21 (s, 1H). LCMS (ESI) calc'd for C6H4BrN3 [M+H]+: 197.96, found: 198, 199.
77%
Stage #1: With potassium acetate; acetic anhydride; acetic acid In chloroform at 20℃; for 0.25 h;
Stage #2: With tert.-butylnitrite In chloroform at 40 - 60℃; for 48.00 h;
To a solution of N-(5-bromo-2-methylpyridin-3-yl)acetamide (M-3) (8.3 g, 36 mmol) in chloroform (550 mL) atambient temperature was added potassium acetate (4.3 g, 43.6 mmol), acetic acid (2.5 mL, 43.6 mmol) and followed by acetic anhydride (6.9 mL, 72.6 mmol). The mixture was stirred at ambient temperature for 15 minutes before being heated to 40 °C. Tert-butyl nitrite (6.5 mL, 54 mmol) was then added dropwise. The reaction was then stirred at 60 °C for 48 hours.The reaction mixture was poured slowly into a saturated solution of sodium bicarbonate (500 mL) at 0 °C. The organic phase was retained and the aqueous phase extracted with dichloromethane (500 mL). The combined organics were then concentrated to a brown oil which was dissolved in methanol (500 mL). Aqueous sodium hydroxide (2 M, 500 mL) was added at 0 °C and the mixture stirred at ambient temperature for 1 hour before the methanolwas removed in vacuo. The aqueous mixture was then extracted with ethyl acetate (3 x 500 mL). The combined organics were dried over magnesium sulfate, and the solvent removed in vacuo to give the title compound as a light brown solid (5.5 g, 27.9 mmol, 77percent). ‘HNMR (400, CD3OD): ö ppm 8.55 (s, 1H), 8.24 (s, 1H), 8.21 (s, 1H). LCMS (ESI) calc’d for C6H4BrN3 [M+H]: 197.96, found: 198, 199.

Reference: [1] Patent: US2011/111046, 2011, A1. Location in patent: Page/Page column 16
[2] Patent: WO2011/58473, 2011, A1. Location in patent: Page/Page column 33; 34
[3] Patent: US2012/108619, 2012, A1. Location in patent: Page/Page column 30
[4] Patent: WO2014/26327, 2014, A1. Location in patent: Page/Page column 89
[5] Patent: WO2014/28589, 2014, A2. Location in patent: Page/Page column 108; 109
[6] Patent: WO2012/87782, 2012, A1
[7] Patent: WO2015/91889, 2015, A1
[8] Patent: US2015/175619, 2015, A1
[9] Patent: WO2016/57834, 2016, A1
  • 2
  • [ 1383735-65-6 ]
  • [ 1150617-54-1 ]
YieldReaction ConditionsOperation in experiment
86% With water; sodium hydroxide In tetrahydrofuran; methanol at 27℃; for 5.00 h; To a solution of 1 -(6-bromo- 1 H-pyrazolo [4,3-b]pyridin- 1 -yl)ethanone (1.4 g, 5.9 mmol) in tetrahydrofuran (20 mL) and methanol (15 mL) was added a solution of sodium hydroxide (0.71 g, 18 mmol) in water (5 mL) at 27 °C. After 5 h, the reaction was neutralized with hydrogen chloride acid (2 mol/L, 10 mL), and the resulting mixture was extracted withethyl acetate (3 x 50 mL). The collected organic extracts were concentrated in vacuo. Purification by flash column chromatography (1 5—30percent ethyl acetate in petroleum ether) afforded 6-bromo-1H-pyrazolo[4,3-b]pyridine (1.0 g, 86percent yield). 1H NMR (400 MHz, Chloroform-d) ö: 10.46 (brs, 1 H), 8.58 (s, 1 H), 8.25 (s, 1 H), 7.98 (s, 1 H).
86% With water; sodium hydroxide In tetrahydrofuran; methanol at 27℃; for 5.00 h; Inert atmosphere To a solution of 1-(6-bromo-1H-pyrazolo[4,3-b]pyridin-1-yl)ethanone (1.4 g, 5.9 mmol) in tetrahydrofuran (20 mL) and methanol (15 mL) was added a solution of sodium hydroxide (0.71 g, 18 mmol) in water (5 mL) at 27° C.
After 5 h, the reaction was neutralized with hydrogen chloride acid (2 mol/L, 10 mL), and the resulting mixture was extracted with ethyl acetate (3*50 mL).
The collected organic extracts were concentrated in vacuo.
Purification by flash column chromatography (15→30percent ethyl acetate in petroleum ether) afforded 6-bromo-1H-pyrazolo[4,3-b]pyridine (1.0 g, 86percent yield).
1H NMR (400 MHz, Chloroform-d) δ 10.46 (brs, 1H), 8.58 (s, 1H), 8.25 (s, 1H), 7.98 (s, 1H).
Reference: [1] Patent: WO2015/91889, 2015, A1. Location in patent: Page/Page column 78
[2] Patent: US2015/175619, 2015, A1. Location in patent: Paragraph 0241; 0242
[3] Patent: WO2012/87782, 2012, A1. Location in patent: Page/Page column 75
[4] Patent: WO2016/57834, 2016, A1. Location in patent: Paragraph 000573
  • 3
  • [ 914358-73-9 ]
  • [ 1150617-54-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2017, vol. 60, # 10, p. 4458 - 4473
[2] Patent: US2010/125089, 2010, A1. Location in patent: Page/Page column 89
[3] Patent: US2011/111046, 2011, A1
[4] Patent: WO2011/58473, 2011, A1
[5] Patent: WO2012/87782, 2012, A1
[6] Patent: WO2014/26327, 2014, A1
[7] Patent: WO2014/28589, 2014, A2
[8] Patent: WO2015/91889, 2015, A1
[9] Patent: US2015/175619, 2015, A1
[10] Patent: WO2016/57834, 2016, A1
[11] Patent: US2012/108619, 2012, A1
  • 4
  • [ 669066-93-7 ]
  • [ 1150617-54-1 ]
YieldReaction ConditionsOperation in experiment
275 mg With hydrazine hydrate In ethylene glycol at 140℃; for 23.00 h; To a solution of the compound [172-1] obtained in the process (1) (426 mg) in ethylene glycol (2.1 mL) was added hydrazine monohydrate (197 µL) at room temperature, and then the reaction mixture was stirred at 140°C for 23 hours. After cooling to room temperature, to the reaction mixture was added water, and extracted with a mixed solution of chloroform/isopropanol (volume ratio 10/1). The obtained organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography to give the titled compound (275 mg) as a yellow solid. 1H-NMR (400 MHz, CDCl3) δ: 10.17 (1H, br), 8.65 (1H, d, J = 1.7 Hz), 8.31 (1H, s), 8.04 (1H, s). ESI-MS found: 198 [M+H]+
275 mg With hydrazine hydrate In ethylene glycol at 140℃; for 23.00 h; (2) Synthesis of 6-bromo-1H-pyrazolo[4,3-b]pyridine [47-2] (hereinafter referred to as a compound [47-2]) To a solution of the compound [47-1] (426 mg) in ethylene glycol (2.1 mL) was added hydrazine monohydrate (197 µL) at room temperature, and the mixture was stirred at 140°C for 23 hours. After cooling to room temperature, water was added to the reaction mixture, and the mixture was extracted with a mixed solution of chloroform/isopropanol (volume ratio 10/1). The obtained organic layer was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography to give the titled compound (275 mg) as a yellow solid. 1H-NMR (400 MHz, CDCl3) δ: 10.17 (1H, br), 8.65 (1H, d, J = 1.7 Hz), 8.31 (1H, s), 8.04 (1H, s). ESI-MS found: 198 [M + H]+
Reference: [1] Patent: EP2669270, 2013, A1. Location in patent: Paragraph 0952-0953
[2] Patent: EP2878594, 2015, A1. Location in patent: Paragraph 0585; 0586
  • 5
  • [ 911434-04-3 ]
  • [ 1150617-54-1 ]
Reference: [1] Patent: US2011/111046, 2011, A1
[2] Patent: WO2011/58473, 2011, A1
[3] Patent: WO2012/87782, 2012, A1
[4] Patent: WO2016/57834, 2016, A1
[5] Patent: US2012/108619, 2012, A1
  • 6
  • [ 911434-05-4 ]
  • [ 1150617-54-1 ]
Reference: [1] Patent: US2011/111046, 2011, A1
[2] Patent: WO2011/58473, 2011, A1
[3] Patent: WO2012/87782, 2012, A1
[4] Patent: WO2014/26327, 2014, A1
[5] Patent: WO2014/28589, 2014, A2
[6] Patent: WO2015/91889, 2015, A1
[7] Patent: US2015/175619, 2015, A1
[8] Patent: WO2016/57834, 2016, A1
[9] Patent: US2012/108619, 2012, A1
  • 7
  • [ 67443-38-3 ]
  • [ 1150617-54-1 ]
Reference: [1] Patent: US2011/111046, 2011, A1
[2] Patent: WO2011/58473, 2011, A1
[3] Patent: WO2012/87782, 2012, A1
[4] Patent: WO2016/57834, 2016, A1
[5] Patent: US2012/108619, 2012, A1
  • 8
  • [ 886373-28-0 ]
  • [ 1150617-54-1 ]
Reference: [1] Patent: EP2669270, 2013, A1
[2] Patent: EP2878594, 2015, A1
Related Products
Historical Records

Related Functional Groups of
[ 1150617-54-1 ]

Bromides

Chemical Structure| 1211516-09-4

[ 1211516-09-4 ]

6-Bromo-1H-pyrazolo[4,3-b]pyridin-3-amine

Similarity: 0.89

Chemical Structure| 1150617-56-3

[ 1150617-56-3 ]

6-Bromo-1-methyl-1H-pyrazolo[4,3-b]pyridine

Similarity: 0.89

Chemical Structure| 1227628-78-5

[ 1227628-78-5 ]

5-Bromo-1H-pyrazolo[4,3-b]pyridine

Similarity: 0.79

Chemical Structure| 633328-33-3

[ 633328-33-3 ]

3-Bromo-1H-pyrazolo[4,3-b]pyridine

Similarity: 0.76

Chemical Structure| 914358-73-9

[ 914358-73-9 ]

5-Bromo-2-methylpyridin-3-amine

Similarity: 0.71

Related Parent Nucleus of
[ 1150617-54-1 ]

Other Aromatic Heterocycles

Chemical Structure| 1211516-09-4

[ 1211516-09-4 ]

6-Bromo-1H-pyrazolo[4,3-b]pyridin-3-amine

Similarity: 0.89

Chemical Structure| 1150617-56-3

[ 1150617-56-3 ]

6-Bromo-1-methyl-1H-pyrazolo[4,3-b]pyridine

Similarity: 0.89

Chemical Structure| 272-52-6

[ 272-52-6 ]

Pyrazolo[4,3-b]pyridine

Similarity: 0.85

Chemical Structure| 194278-45-0

[ 194278-45-0 ]

3-Methyl-1H-pyrazolo[4,3-b]pyridine

Similarity: 0.81

Chemical Structure| 1227628-78-5

[ 1227628-78-5 ]

5-Bromo-1H-pyrazolo[4,3-b]pyridine

Similarity: 0.79